Cargando…
Treatment of adult MPSI mouse brains with IDUA-expressing mesenchymal stem cells decreases GAG deposition and improves exploratory behavior
BACKGROUND: Mucopolysaccharidosis type I (MPSI) is caused by a deficiency in alpha-L iduronidase (IDUA), which leads to lysosomal accumulation of the glycosaminoglycans (GAGs) dermatan and heparan sulfate. While the currently available therapies have good systemic effects, they only minimally affect...
Autores principales: | da Silva, Flávia Helena, Pereira, Vanessa Gonçalves, Yasumura, Eduardo G, Tenório, Lígia Zacchi, de Carvalho, Leonardo Pinto, Lisboa, Bianca Cristina Garcia, Matsumoto, Priscila Keiko, Stilhano, Roberta Sessa, Samoto, Vivian Y, Calegare, Bruno Frederico Aguilar, Brandão, Letícia de Campos, D’Almeida, Vânia, Filippo, Thaís RM, Porcionatto, Marimélia, Toma, Leny, Nader, Helena Bonciani, Valero, Valderez Bastos, Camassola, Melissa, Nardi, Nance Beyer, Han, Sang Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404940/ https://www.ncbi.nlm.nih.gov/pubmed/22520214 http://dx.doi.org/10.1186/1479-0556-10-2 |
Ejemplares similares
-
MPSI Manifestations and Treatment Outcome: Skeletal Focus
por: De Ponti, Giada, et al.
Publicado: (2022) -
Treatment of Mouse Limb Ischemia with an Integrative Hypoxia-Responsive Vector Expressing the Vascular Endothelial Growth Factor Gene
por: Yasumura, Eduardo Gallatti, et al.
Publicado: (2012) -
Current Practices for U.S. Newborn Screening of Pompe Disease and MPSI
por: Ames, Elizabeth G., et al.
Publicado: (2020) -
Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts
por: Vicente, Carolina Meloni, et al.
Publicado: (2013) -
CASE SERIES OF PATIENTS UNDER BIWEEKLY TREATMENT WITH LARONIDASE: A
REPORT OF A SINGLE CENTER EXPERIENCE
por: Kyosen, Sandra Obikawa, et al.
Publicado: (2019)